TLON- mc 30m, possible pipeline value:
this is from member perdooky, like i said this upcoming approval
is a very big deal.
Quote:
Marqibo has a market potential of about $100-$150 million annually. However, their next product in the pipeline, Menadione, has a market potential of $1 to $2 billion annually. Also, you need to consider an approval of Marqibo means that this liposomal encapsulation technology works which they will be seeking approval for other indications over time.
For example, from their corporate presentation here is the sales potential for the other indications they are pursuing:
ADVANCED R/R ADULT Ph- ALLa
$100+M/Yr
2,600 new cases per year
FRONT-LINE Ph- ALL
$450+M/Yr
4,000 new cases per year
PEDIATRIC ALL
$800M+/Yr
7,200 cases per year
FRONT-LINE ELDERLY AGGRESSIVE B-CELL NON-HODGKIN’S LYMPHOMA
$2B+/Yr
40,000 new cases per year
